パイロジェン検査市場：製品タイプ、検査タイプ、エンドユーザー別-2025-2030年の世界予測

パイロジェン検査市場は、2023年に12億4,000万米ドルと評価され、2024年には13億8,000万米ドルに達すると予測され、CAGR 11.64%で成長し、2030年には26億8,000万米ドルに達すると予測されています。

パイロジェン検査は、医薬品および医療機器産業において、発熱や人体への免疫学的有害反応を引き起こす可能性のある汚染物質が製品に含まれていないことを保証する重要なプロセスです。パイロジェン検査の必要性は、患者の安全性を守り、製品の有効性を確保するための厳しい規制義務から生じており、注射薬、ワクチン、医療機器などの多様な分野での応用に大きく貢献しています。最終用途産業は主に製薬、バイオテクノロジー、医療機器企業です。パイロジェン検査市場に影響を与える主な発展要因としては、医薬品の研究開発活動の増加、革新的な医薬品開拓を必要とする慢性疾患の急増、バイオ医薬品企業の設立増加などが挙げられます。さらに、バイオテクノロジーの進歩により、単球活性化試験（MAT）のようなin vitro試験のような代替試験法への道が開かれ、従来の動物ベースの試験よりも倫理的・技術的に優れているため、潜在的なビジネスチャンスがもたらされています。生物学的製剤やバイオシミラーへの移行が進んでいるため、効率的なソリューションに対する需要が高まっており、さらなる市場展望が期待されています。しかし、この市場は、高度な試験方法に関連する高コストや、製品承認をしばしば遅らせる複雑な規制の枠組みといった限界に直面しています。また、生体内条件を正確にシミュレートできる試験を開発するための技術的な複雑さも課題となっています。このようなハードルにもかかわらず、技術革新の余地がある分野には、より費用対効果が高く、より迅速で正確なin vitro検査法の開発や、AIや機械学習を活用して検出・分析プロセスを合理化することなどがあります。パイロジェン検査市場の性質は競争的であり、製品ポートフォリオを拡大し市場での存在感を高めるための技術的進歩や買収に大きな焦点が当てられています。成長を目指す企業は、戦略的提携を通じてこれらの分野をターゲットとし、新規ソリューションの研究開発に投資し、進化する規制基準へのコンプライアンスを確保することで、リスクを最小限に抑え、市場獲得を最大化することができます。

市場力学：急速に進化するパイロジェン検査市場の主要市場インサイトを公開

パイロジェン検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の感染症および慢性疾患の罹患率の上昇
  • 医薬品、生物製剤、医療機器製品の生産量の増加
  • 世界の保健当局による厳しい規制と基準
• 市場抑制要因
  • 高度なパイロジェン検査手法に伴う高コスト
• 市場機会
  • パイロジェン検査技術の技術的進歩
  • パイロジェン検査法の展開を拡大するためのベンダーと製薬企業との協力関係
• 市場の課題
  • パイロジェン検査に関連する運用面および倫理面での懸念

ポーターの5つの力：パイロジェン検査市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、パイロジェン検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：パイロジェン検査市場における外部からの影響の把握

外部マクロ環境要因は、パイロジェン検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析パイロジェン検査市場における競合情勢の把握

パイロジェン検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスパイロジェン検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、パイロジェン検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨パイロジェン検査市場における成功への道筋を描く

パイロジェン検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で感染症や慢性疾患の発生率が上昇
    • 医薬品、生物製剤、医療機器製品の生産増加
    • 世界中の保健当局が定める厳格な規制と基準
  • 抑制要因
    • 高度なパイロジェン検査メソッドに関連する高コスト
  • 機会
    • パイロジェン検査テクノロジーの技術的進歩
    • 市場ベンダーと製薬会社の協力によりパイロジェン検査メソッドの導入を拡大
  • 課題
    • パイロジェン検査に関連する運用上および倫理上の懸念
• 市場セグメンテーション分析
  • 製品タイプ：検査プロセスを自動化、促進、強化するためのアッセイ、キット、試薬の需要が高まっています
  • テストの種類：高い感度と信頼性により、LALテストの使用が増加しています。
  • エンドユーザー：バイオテクノロジー企業全体でパイロジェン検査の採用が急増
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 パイロジェン検査市場：製品タイプ別

• アッセイ、キット、試薬
• 機器
• サービス

第7章 パイロジェン検査市場テストタイプ別

• リムルスアメーバ細胞溶解液
  • 発色性検査
  • ゲル凝固検査
  • 濁度測定試験
• 単球活性化試験
• ウサギ発熱物質試験
• 組み換えカスケード試薬
• 組み換え因子C

第8章 パイロジェン検査市場：エンドユーザー別

• バイオテクノロジー企業
• 医療機器企業
• 製薬会社

第9章 南北アメリカのパイロジェン検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のパイロジェン検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのパイロジェン検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 富士フイルムとPredictive Oncologyが細菌エンドトキシン検査の改善に向け提携
  • 組み換え因子Cを用いた製薬用水中の細菌エンドトキシン検査の新たな柔軟性
  • チャールズリバーラボラトリーズ、効率的で動物を使わない試験を実現するエンドセーフトリリウムrCRカートリッジを発売
  • ロンザ、先進の迅速MATシステムを発表
  • ウィッカムマイクロ社、医療・製薬分野の需要増大に対応するため細菌エンドトキシン検査施設を拡張
  • MiCAN Technologies、革新的なMylcMAT製品で動物を使わないパイロジェン検査を推進するため2億円を調達
  • ロンザは、品質管理ラボでの発熱物質およびエンドトキシン検査用のネビュラ吸光度計を導入しました。
  • 新しいISO規格 ISO 11737-3：2023は、医療製品における細菌エンドトキシン試験のガイドラインを強化します
• 戦略分析と提言
  • ノボノルディスク A/S
  • 富士フイルムホールディングス株式会社
  • ウォーターズコーポレーション
  • メルク
  • チャールズリバーラボラトリーズインターナショナル株式会社

企業一覧

• Accugen Laboratories, Inc.
• Almac Group
• Associates of Cape Cod, Inc.
• bioMerieux SA
• Charles River Laboratories International, Inc.
• Corning Incorporated
• Creative Bioarray
• Eurofins Scientific SE
• FUJIFILM Holdings Corporation
• Genscript Biotech Corporation
• Hycult Biotechnology B.V.
• IDEXX Laboratories, Inc.
• Incell Corporation LLC
• Indoor Biotechnologies, Inc.
• InvivoGen S.A.S.
• Laboratory Corporation of America Holdings
• Lonza Group AG
• Lucideon Limited
• MAT BioTech B.V.
• Merck KGaA
• Microcoat Biotechnologie GmbH
• Minerva Biolabs GmbH
• Nelson Laboratories, LLC by Sotera Health Company
• North American Science Associates, LLC
• Novo Nordisk A/S
• Pacific Biolabs Inc.
• QIAGEN N.V.
• Solvias AG
• Steris PLC
• Thermo Fisher Scientific Inc.
• Veolia Environnement S.A.
• Waters Corporation
• Wickham Micro Limited by Cormica Group
• WuXi AppTec Co., Ltd.

LIST OF FIGURES

• FIGURE 1. PYROGEN TESTING MARKET RESEARCH PROCESS
• FIGURE 2. PYROGEN TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. PYROGEN TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL PYROGEN TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL PYROGEN TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. PYROGEN TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL PYROGEN TESTING MARKET SIZE, BY ASSAYS, KITS, & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL PYROGEN TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL PYROGEN TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL PYROGEN TESTING MARKET SIZE, BY CHROMOGENIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL PYROGEN TESTING MARKET SIZE, BY GEL CLOT TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL PYROGEN TESTING MARKET SIZE, BY TURBIDIMETRIC TESTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL PYROGEN TESTING MARKET SIZE, BY MONOCYTE ACTIVATION TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL PYROGEN TESTING MARKET SIZE, BY RABBIT PYROGEN TEST, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT CASCADE REAGENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL PYROGEN TESTING MARKET SIZE, BY RECOMBINANT FACTOR C, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL PYROGEN TESTING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL PYROGEN TESTING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL PYROGEN TESTING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. CANADA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. CANADA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 41. CANADA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES PYROGEN TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. CHINA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 62. CHINA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 63. CHINA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 67. INDIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA PYROGEN TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. ITALY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 135. ITALY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 136. ITALY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. POLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 151. POLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 152. POLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. QATAR PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 155. QATAR PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 156. QATAR PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY LIMULUS AMOEBOCYTE LYSATE, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM PYROGEN TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 193. PYROGEN TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. PYROGEN TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Pyrogen Testing Market was valued at USD 1.24 billion in 2023, expected to reach USD 1.38 billion in 2024, and is projected to grow at a CAGR of 11.64%, to USD 2.68 billion by 2030.

Pyrogen testing is a critical process in the pharmaceutical and medical devices industries, ensuring that products are free from contaminants that can cause fever and adverse immunological responses in humans. The necessity for pyrogen testing arises from stringent regulatory mandates to safeguard patient safety and ensure product efficacy, contributing significantly to its application across diverse segments such as injectable drugs, vaccines, and medical devices. End-use industries predominantly include pharmaceuticals, biotechnology, and medical devices companies. Key growth factors influencing the pyrogen testing market include increasing pharmaceutical R&D activities, surging prevalence of chronic diseases necessitating innovative drug development, and the rise in biopharmaceutical firm establishment. Moreover, advancements in biotechnology have opened avenues for alternative testing methods, such as in vitro tests like the Monocyte Activation Test (MAT), which present potential opportunities owing to their ethical and technical advantages over traditional animal-based tests. The ongoing shift toward biologicals and biosimilars creates an extra demand for efficacious pyrogen testing solutions, offering further market prospects. However, the market faces limitations like high costs associated with advanced testing methods and complex regulatory frameworks that often delay product approvals. Challenges also include technical intricacies in developing tests that can accurately simulate in vivo conditions. Despite these hurdles, areas ripe for innovation include developing more cost-effective, faster, and precise in vitro testing methods, as well as harnessing AI and machine learning to streamline detection and analysis processes. The nature of the pyrogen testing market is competitive, with significant focus on technological advancements and acquisitions to broaden product portfolios and enhance market presence. Companies seeking growth can target these areas through strategic collaborations, investing in R&D for novel solutions, and ensuring compliance with evolving regulatory standards to minimize risks and maximize market capture.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Pyrogen Testing Market

The Pyrogen Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of infectious and chronic diseases worldwide
  • Increasing production of pharmaceuticals, biologics, and medical device products
  • Stringent regulations and standards set by health authorities worldwide
• Market Restraints
  • High cost associated with the advanced pyrogen testing methods
• Market Opportunities
  • Technological advancements in pyrogen testing technologies
  • Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
• Market Challenges
  • Operational and ethical concerns associated with pyrogen testing

Porter's Five Forces: A Strategic Tool for Navigating the Pyrogen Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Pyrogen Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Pyrogen Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Pyrogen Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Pyrogen Testing Market

A detailed market share analysis in the Pyrogen Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Pyrogen Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Pyrogen Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Pyrogen Testing Market

A strategic analysis of the Pyrogen Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Pyrogen Testing Market, highlighting leading vendors and their innovative profiles. These include Accugen Laboratories, Inc., Almac Group, Associates of Cape Cod, Inc., bioMerieux SA, Charles River Laboratories International, Inc., Corning Incorporated, Creative Bioarray, Eurofins Scientific SE, FUJIFILM Holdings Corporation, Genscript Biotech Corporation, Hycult Biotechnology B.V., IDEXX Laboratories, Inc., Incell Corporation LLC, Indoor Biotechnologies, Inc., InvivoGen S.A.S., Laboratory Corporation of America Holdings, Lonza Group AG, Lucideon Limited, MAT BioTech B.V., Merck KGaA, Microcoat Biotechnologie GmbH, Minerva Biolabs GmbH, Nelson Laboratories, LLC by Sotera Health Company, North American Science Associates, LLC, Novo Nordisk A/S, Pacific Biolabs Inc., QIAGEN N.V., Solvias AG, Steris PLC, Thermo Fisher Scientific Inc., Veolia Environnement S.A., Waters Corporation, Wickham Micro Limited by Cormica Group, and WuXi AppTec Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Pyrogen Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Assays, Kits, & Reagents, Instruments, and Services.
• Based on Test Type, market is studied across Limulus Amoebocyte Lysate, Monocyte Activation Test, Rabbit Pyrogen Test, Recombinant Cascade Reagent, and Recombinant Factor C. The Limulus Amoebocyte Lysate is further studied across Chromogenic Tests, Gel Clot Tests, and Turbidimetric Tests.
• Based on End-User, market is studied across Biotechnology Companies, Medical Device Companies, and Pharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of infectious and chronic diseases worldwide
    • 5.1.1.2. Increasing production of pharmaceuticals, biologics, and medical device products
    • 5.1.1.3. Stringent regulations and standards set by health authorities worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the advanced pyrogen testing methods
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in pyrogen testing technologies
    • 5.1.3.2. Collaboration between market vendors and pharma companies to expand the deployment of pyrogen testing methods
  • 5.1.4. Challenges
    • 5.1.4.1. Operational and ethical concerns associated with pyrogen testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product Type: Increasing need of assays, kits, & reagents to automate, facilitate, or enhance the testing processes
  • 5.2.2. Test Type: Rising usage of the LAL test due to its high sensitivity and reliability
  • 5.2.3. End-User: Burgeoning adoption of pyrogen testing across biotechnology companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Pyrogen Testing Market, by Product Type

• 6.1. Introduction
• 6.2. Assays, Kits, & Reagents
• 6.3. Instruments
• 6.4. Services

7. Pyrogen Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Limulus Amoebocyte Lysate
  • 7.2.1. Chromogenic Tests
  • 7.2.2. Gel Clot Tests
  • 7.2.3. Turbidimetric Tests
• 7.3. Monocyte Activation Test
• 7.4. Rabbit Pyrogen Test
• 7.5. Recombinant Cascade Reagent
• 7.6. Recombinant Factor C

8. Pyrogen Testing Market, by End-User

• 8.1. Introduction
• 8.2. Biotechnology Companies
• 8.3. Medical Device Companies
• 8.4. Pharmaceutical Companies

9. Americas Pyrogen Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Pyrogen Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Pyrogen Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. FUJIFILM and Predictive Oncology Partner to Improve Bacterial Endotoxin Testing
  • 12.3.2. New Flexibility for Bacterial Endotoxin Testing in Pharmaceutical Waters with Recombinant Factor C
  • 12.3.3. Charles River Laboratories Launches Endosafe Trillium rCR Cartridge for Efficient, Animal-Free Testing
  • 12.3.4. Lonza Introduces Advanced Rapid MAT Systems
  • 12.3.5. Wickham Micro Expands Bacterial Endotoxin Testing Facilities to Meet Rising Demand in Medical and Pharmaceutical Sectors
  • 12.3.6. MiCAN Technologies Raises JPY 200 Million to Advance Animal-Free Pyrogen Testing with Innovative MylcMAT Product
  • 12.3.7. Lonza Introduced the Nebula Absorbance Reader for Pyrogen and Endotoxin Testing in Quality Control Labs
  • 12.3.8. New ISO Standard ISO 11737-3:2023 Enhances Guidelines for Bacterial Endotoxin Testing in Medical Products
• 12.4. Strategy Analysis & Recommendation
  • 12.4.1. Novo Nordisk A/S
  • 12.4.2. FUJIFILM Holdings Corporation
  • 12.4.3. Waters Corporation
  • 12.4.4. Merck KGaA
  • 12.4.5. Charles River Laboratories International, Inc.

Companies Mentioned

• 1. Accugen Laboratories, Inc.
• 2. Almac Group
• 3. Associates of Cape Cod, Inc.
• 4. bioMerieux SA
• 5. Charles River Laboratories International, Inc.
• 6. Corning Incorporated
• 7. Creative Bioarray
• 8. Eurofins Scientific SE
• 9. FUJIFILM Holdings Corporation
• 10. Genscript Biotech Corporation
• 11. Hycult Biotechnology B.V.
• 12. IDEXX Laboratories, Inc.
• 13. Incell Corporation LLC
• 14. Indoor Biotechnologies, Inc.
• 15. InvivoGen S.A.S.
• 16. Laboratory Corporation of America Holdings
• 17. Lonza Group AG
• 18. Lucideon Limited
• 19. MAT BioTech B.V.
• 20. Merck KGaA
• 21. Microcoat Biotechnologie GmbH
• 22. Minerva Biolabs GmbH
• 23. Nelson Laboratories, LLC by Sotera Health Company
• 24. North American Science Associates, LLC
• 25. Novo Nordisk A/S
• 26. Pacific Biolabs Inc.
• 27. QIAGEN N.V.
• 28. Solvias AG
• 29. Steris PLC
• 30. Thermo Fisher Scientific Inc.
• 31. Veolia Environnement S.A.
• 32. Waters Corporation
• 33. Wickham Micro Limited by Cormica Group
• 34. WuXi AppTec Co., Ltd.